6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- $155 - $1331
- Product name: 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- CAS: 1228665-68-6
- MF: C12H7IN2O2
- MW: 338.1
- EINECS:
- MDL Number:MFCD15530316
- Synonyms:6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine;Furo[3,2-b]pyridine, 6-[(3-iodo-2-pyridinyl)oxy]-
5 prices
Selected condition:
Brand
- AK Scientific
- Crysdot
- Matrix Scientific
- TRC
Package
- 50mg
- 100mg
- 1g
- ManufacturerAK Scientific
- Product number2597AD
- Product description6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- Packaging1g
- Price$1331
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11320985
- Product description6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine 95+%
- Packaging1g
- Price$904
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number055659
- Product description6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- Packaging100mg
- Price$237
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberI719455
- Product description6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- Packaging50mg
- Price$155
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberI719455
- Product description6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine
- Packaging100mg
- Price$240
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 2597AD | 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine | 1g | $1331 | 2021-12-16 | Buy |
Crysdot | CD11320985 | 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine 95+% | 1g | $904 | 2021-12-16 | Buy |
Matrix Scientific | 055659 | 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine | 100mg | $237 | 2021-12-16 | Buy |
TRC | I719455 | 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine | 50mg | $155 | 2021-12-16 | Buy |
TRC | I719455 | 6-(3-Iodopyridin-2-yloxy)furo[3,2-b]pyridine | 100mg | $240 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|